| Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway KJ Kurppa, Y Liu, C To, T Zhang, M Fan, A Vajdi, EH Knelson, Y Xie, ... Cancer cell 37 (1), 104-122. e12, 2020 | 319 | 2020 |
| Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status B Ricciuti, KC Arbour, JJ Lin, A Vajdi, N Vokes, L Hong, J Zhang, ... Journal of Thoracic Oncology 17 (3), 399-410, 2022 | 180 | 2022 |
| Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity NR Mahadevan, EH Knelson, JO Wolff, A Vajdi, M Saigí, M Campisi, ... Cancer discovery 11 (8), 1952-1969, 2021 | 91 | 2021 |
| Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade K Sehgal, A Portell, EV Ivanova, PH Lizotte, NR Mahadevan, JR Greene, ... The Journal of clinical investigation 131 (2), 2021 | 40 | 2021 |
| Plasticity in the absence of NOTCH uncovers a RUNX2-dependent pathway in small cell lung cancer D Hong, EH Knelson, Y Li, YT Durmaz, W Gao, E Walton, A Vajdi, T Thai, ... Cancer research 82 (2), 248-263, 2022 | 19 | 2022 |
| The Extracellular Milieu of Toxoplasma's Lytic Cycle Drives Lab Adaptation, Primarily by Transcriptional Reprogramming VA Primo Jr, Y Rezvani, A Farrell, CQ Murphy, J Lou, A Vajdi, GT Marth, ... Msystems 6 (6), e01196-21, 2021 | 15 | 2021 |
| Human gait database for normal walk collected by smartphone accelerometer A Vajdi, MR Zaghian, NR Dehkordi, E Rastegari, K Maroofi, S Farahmand, ... arXiv preprint arXiv:1905.03109, 2019 | 15 | 2019 |
| MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer R Yoshida, M Saigi, T Tani, BF Springer, H Shibata, S Kitajima, ... Cancer research 82 (21), 4079-4092, 2022 | 11 | 2022 |
| A new dp algorithm for comparing gene expression data using geometric similarity A Vajdi, N Haspel, H Banaee 2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2015 | 11 | 2015 |
| Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1 HY Chen, YT Durmaz, Y Li, AH Sabet, A Vajdi, T Denize, E Walton, ... Nature Communications 13 (1), 4998, 2022 | 10 | 2022 |
| Patch-DCA: improved protein interface prediction by utilizing structural information and clustering DCA scores A Vajdi, K Zarringhalam, N Haspel Bioinformatics 36 (5), 1460-1467, 2020 | 10 | 2020 |
| Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment PM Szabo, A Vajdi, N Kumar, MY Tolstorukov, BJ Chen, R Edwards, ... Scientific Reports 13 (1), 3051, 2023 | 9 | 2023 |
| Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status. B Ricciuti, KC Arbour, JJ Lin, N Vokes, A Vajdi Hoojghan, YY Li, ... Journal of Clinical Oncology 38 (15_suppl), e15113-e15113, 2020 | 8 | 2020 |
| Clustering protein conformations using a dynamic programming based similarity measurement A Vajdi, N Haspel 8th International Conference on Bioinformatics and Computational Biology …, 2016 | 6 | 2016 |
| Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC. CM Rudin, HR Kim, A Navarro, M Gottfried, S Peters, T Csoszi, ... Journal of Clinical Oncology 41 (16_suppl), 8503-8503, 2023 | 5 | 2023 |
| The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells C Noyes, S Kitajima, F Li, Y Suita, S Miriyala, S Isaac, N Ahsan, E Knelson, ... Communications Biology 6 (1), 65, 2023 | 5 | 2023 |
| Integrating co-evolutionary information in monte carlo based method for proteins trajectory simulation A Vajdi, A Joshi, N Haspel Proceedings of the 10th ACM International Conference on Bioinformatics …, 2019 | 5 | 2019 |
| Detecting chromosomal structural variation using jaccard distance and parallel architecture H Mohebbi, A Vajdi, N Haspel, D Simovici 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2017 | 5 | 2017 |
| P14. 26 diminished efficacy of PD-(L) 1 inhibition in STK11-and KEAP1-Mutant lung adenocarcinoma is impacted by KRAS mutation status B Ricciuti, K Arbour, J Lin, A Vajdi, M Tolstorukov, L Hong, J Zhang, ... Journal of Thoracic Oncology 16 (3), S341, 2021 | 4 | 2021 |
| Diminished efficacy of PD-(L) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status B Ricciuti, K Arbour, J Lin, A Vajdi, M Tolstorukov, L Hong, J Zhang, ... JOURNAL OF THORACIC ONCOLOGY 16 (3), S341-S341, 2021 | 4 | 2021 |
Nurit HaspelAssociate Professor of Computer Science, University of Massachusetts BostonVerifierad e-postadress på umb.edu
